Angioflow BioFlo Port Lawsuit | 2026 Latest Updates

Patients who received AngioDynamics port catheters, including the BioFlo port, allege the devices fractured, migrated inside the body or became infected after implant. Some say they needed surgery to remove or replace them, and plaintiffs allege defective design and materials, plus failure to warn. Claims against AngioDynamics, Inc. and Navilyst Medical, Inc. are consolidated in MDL No. 3125 in Southern California. The transfer order entered on October 11, 2024 placed the litigation in pretrial proceedings before Judge Jinsook Ohta. Magistrate Judge Valerie E. Torres also sits on the case, numbered 3:24-md-3125-JO-VET. No case is limited to the BioFlo port.

Latest Angioflow BioFlo Port Lawsuit Updates

October 15, 2024: Judge Ohta Sends Four Related Cases to the MDL

An order transferring cases from Judge Jinsook Ohta of the Southern District of California reassigned four related cases into MDL No. 3125 on October 15, 2024 [1]. The cases include Koester, Hyder, Seim and Hicks v. AngioDynamics, Inc. et al. They now proceed before Judge Ohta in consolidated pretrial proceedings.

October 11, 2024: Panel Creates MDL No. 3125 for Port Catheters

The Judicial Panel on Multidistrict Litigation entered a transfer order on October 11, 2024 that created MDL No. 3125 [2]. The case was assigned to District Judge Jinsook Ohta and Magistrate Judge Valerie E. Torres. The order places the port catheter cases in one federal court, where the shared pretrial work for all of them takes place.

What Is a Port?

According to the National Cancer Institute, a port is a small, round disc placed under the skin during minor surgery. A catheter connects the port to a large vein, most often in the chest [3]. A nurse can insert a needle into the port to give chemotherapy or draw blood. A surgeon places the port before treatment begins, and it stays in place until the course of treatment is finished.

Who May Be Affected?

People who received an implanted port catheter made by AngioDynamics or Navilyst Medical and later had a complication fit this litigation. These two companies are the defendants. Matching circumstances include:

• an infection at or around the implanted port site
• a port catheter that fractured or migrated inside the body
• a port that was removed or replaced after a complication

The National Cancer Institute tells patients to watch for signs of infection around a port. Check the maker and model on your implant card. Only an individual legal review of your own records can say whether you qualify.

Reported Injuries or Damages

Plaintiffs in the port catheter cases allege that catheters fractured, that fragments migrated, and that infection followed. They also allege surgery to remove or replace the port. The allegations are not court findings. A 2016 study of 85 children with ports at an Iranian hospital found complications in 30.6% of patients, most often infection and malfunction [4]. It also lists port fracture and displacement among known risks.

Evidence to Preserve

Keep these records and items from the day of implant through any complication, and store paper and digital copies together:

• The port brand, model and lot or serial number from the implant card or operative report
• The dates of implant and of removal, if the port was taken out
• Hospital and surgeon records for the implant and any follow-up care
• Imaging that shows a fracture or migration of the catheter
• Infection and antibiotic records from your treating providers
• The removed device or fragments, if you kept them, stored safely
• Bills and photographs related to the port and the complication

Filing Deadlines

A port complication claim has a filing deadline, and state law sets it. The deadline varies with where you live and with when the injury and the diagnosis happened. A late filing can end a claim even when the facts behind it are strong. A lawyer can check which deadline applies to your port and state. Ask promptly, before records or dates become hard to find.

Frequently Asked Questions

Is There an Angioflow BioFlo Port Lawsuit?

An Angioflow BioFlo port lawsuit has no docket of its own. Port catheter claims proceed together in one shared federal case, the Port Catheter Products Liability Litigation, transferred by order entered October 11, 2024.

What Is the AngioDynamics Port Catheter MDL?

The AngioDynamics port catheter MDL is a group of federal cases combined for pretrial proceedings under Title 28 U.S.C. 1407. One judge handles the shared pretrial work, instead of many courts handling it separately.

Which Cases Joined the AngioDynamics MDL in October 2024?

The cases that joined the AngioDynamics MDL by reassignment in October 2024 carry the numbers 3:24-cv-01383, 3:24-cv-01521, 3:24-cv-01675 and 3:24-cv-01816. The court listed them as related to the pending MDL proceedings.

What Does the Research Say About Port Catheter Fracture and Infection?

Research on port catheter fracture and infection includes a study published March 15, 2016. Of the 85 children studied, 26 had port complications, and infection and catheter malfunction were the most common problems.

References

1. https://www.govinfo.gov/content/pkg/USCOURTS-casd-3_24-cv-01816/pdf/USCOURTS-casd-3_24-cv-01816-0.pdf
2. https://www.courtlistener.com/docket/69255166/in-re-angiodynamics-inc-and-navilyst-medical-inc-port-catheter/
3. https://www.cancer.gov/about-cancer/treatment/types/chemotherapy
4. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4867165/